Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma.

Intermittent or recreational exposure to sunlight is thought to contribute to development of human cutaneous melanoma. We investigated the incidence of ras oncogene mutation in human cutaneous melanoma in connection to sun-exposed body sites in the patient, using a large series of DNA samples derived from paraffin-embedded material as well as from fresh tumor samples and cell lines. We first show that, of the ras family, predominantly N-ras is activated (15%), whereas rarely H-ras or K-ras are mutated. The occurrence of N-ras mutations correlates with continuous exposure to sunlight of the primary tumor site. Of all tumors initiated on chronically sun-exposed body sites, 26% contained mutated N-ras, in contrast to 0% of sun-protected melanomas. Melanoma lesions obtained from patients from North or Central Europe contained fewer N-ras mutations (12%) as compared with patients from Australia (24%). Mutations were specifically associated with nodular melanoma and to a lesser extent with lentigo malignant melanoma. N-ras mutations did not correlate with metastasis or survival parameters. This study identifies a subset of cutaneous melanomas that contain in the primary lesion ultraviolet-induced N-ras mutations, which are maintained through further progression.

[1]  A. Streetly,et al.  Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. , 1995, International journal of epidemiology.

[2]  W. Kast,et al.  Induction and characterization of cytotoxic T‐lymphocytes recognizing a mutated p21ras peptide presented by HLA‐A*0201 , 1995, International journal of cancer.

[3]  D I McLean,et al.  Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma. , 1995, Archives of dermatology.

[4]  T. Yagi,et al.  Mutations in ras genes in cells cultured from mouse skin tumors induced by ultraviolet irradiation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  P. Kleihues,et al.  Absence of p53 gene mutations in cutaneous melanoma. , 1994, The Journal of investigative dermatology.

[6]  H. Soyer,et al.  Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. , 1994, The Journal of investigative dermatology.

[7]  J. Hoeffler,et al.  Ras mutations in human melanoma: a marker of malignant progression. , 1994, The Journal of investigative dermatology.

[8]  J. Elwood,et al.  Etiology, epidemiology, risk factors, and public health issues of melanoma. , 1994, Current opinion in oncology.

[9]  N. Dumaz,et al.  Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. MacKie,et al.  Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups , 1993, The Lancet.

[11]  A. Ziegler,et al.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Robert,et al.  High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. , 1993, Cancer research.

[13]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Ananthaswamy Hn,et al.  Transformation of NIH3T3 cells by transfection with UV-irradiated human c-Ha-ras-1 proto-oncogene DNA. , 1991 .

[15]  D. Housman,et al.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.

[16]  S. Hirohashi,et al.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. , 1991, Cancer research.

[17]  C. Harris,et al.  Chemical and physical carcinogenesis: advances and perspectives for the 1990s. , 1991, Cancer research.

[18]  P. O’Connell,et al.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 , 1990, Cell.

[19]  S. Rodenhuis,et al.  K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.

[20]  J. Bos,et al.  Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. , 1990, The Journal of investigative dermatology.

[21]  F. McCormick,et al.  N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. , 1990, Blood.

[22]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[23]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[24]  L. J. Veer,et al.  N-ras mutations in human cutaneous melanoma from sun-exposed body sites , 1989, Molecular and cellular biology.

[25]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Bos,et al.  Establishment and characterization of a melanoma cell line from a xeroderma pigmentosum patient: activation of N-ras at a potential pyrimidine dimer site. , 1989, Cancer research.

[27]  H. Ananthaswamy,et al.  Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites. , 1988, Cancer research.

[28]  G. Cooper,et al.  Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins , 1988, Molecular and cellular biology.

[29]  D. Birnbaum,et al.  Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay. , 1988, Cancer research.

[30]  F. McCormick,et al.  A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. , 1987, Science.

[31]  J. Roder,et al.  Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility , 1986, Nature.

[32]  B. Armstrong,et al.  Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. , 1986, Journal of the National Cancer Institute.

[33]  C. Der,et al.  Biological and biochemical properties of human ras H genes mutated at codon 61 , 1986, Cell.

[34]  J. Elwood,et al.  Cutaneous melanoma in relation to intermittent and constant sun exposure—the western canada melanoma study , 1985, International journal of cancer.

[35]  G. Currie,et al.  Activation of N-ras in a human melanoma cell line , 1985, Molecular and cellular biology.

[36]  P. Seeburg,et al.  Biological properties of human c-Ha-ras1 genes mutated at codon 12 , 1984, Nature.

[37]  S. Hirohashi,et al.  Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Armstrong,et al.  Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. , 1984, Journal of the National Cancer Institute.

[39]  L. Old,et al.  Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? , 1984, Nature.

[40]  R. MacKie,et al.  Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in scotland. , 1982, British Journal of Cancer.

[41]  A. Verbeek,et al.  Trends in mortality from malignant cutaneous melanoma in The Netherlands, 1950-1988. , 1992, European journal of cancer.

[42]  W. Pierceall,et al.  Transformation of NIH3T3 cells by transfection with UV-irradiated human c-Ha-ras-1 proto-oncogene DNA. , 1991, Oncogene.

[43]  T. Sekiya,et al.  Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1990, Oncogene.

[44]  C. Cordon-Cardo,et al.  Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. , 1989, Oncogene.

[45]  F. McCormick,et al.  ras mutations in human melanotic lesions: K-ras activation is a frequent and early event in melanoma development. , 1989, Oncogene research.

[46]  J. Bos,et al.  Activation of N-ras induced by ultraviolet irradiation in vitro. , 1988, Oncogene research.